Charles Schwab Investment Management »

Allogene Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 733k 3.21
2023-09-30 $2.5M 781k 3.17
2023-06-30 $3.3M 665k 4.97
2023-03-31 $3.2M 650k 4.94
2022-12-31 $4.1M 649k 6.29
2022-09-30 $6.9M 636k 10.80
2022-06-30 $6.2M 544k 11.40
2022-03-31 $4.8M 531k 9.11
2021-12-31 $8.0M 537k 14.92
2021-09-30 $14M 531k 25.70
2021-06-30 $17M 634k 26.08
2021-03-31 $20M 563k 35.30
2020-12-31 $14M 550k 25.24
2020-09-30 $20M 540k 37.71
2020-06-30 $23M 531k 42.82
2020-03-31 $7.8M 402k 19.44
2019-12-31 $10M 395k 25.98
2019-09-30 $11M 387k 27.26
2019-06-30 $5.1M 191k 26.85
2019-03-31 $4.4M 153k 28.91
2018-12-31 $3.9M 144k 26.93